PIM kinases as rational therapeutic targets in lymphoid malignancies.
2011/03/B/NZ4/02020
Keywords
Descriptors
- NZ4_5: Patomorfologia
- NZ1_11: Inne zagadnienia pokrewne
- NZ2_11: Epidemiologia genetyczna
Panel
NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution
Instytut Hematologii i Transfuzjologii
Voivodeship: mazowieckie
Principal investigator (from the host institution)
dr hab. Przemysław Juszczyński
Number of co-investigators in the project: 3
Call
OPUS 2 – announced on 2011-09-15
- Amount awarded
- 781 500 PLN
- Project start date
- 2012-12-21
- Project end date
- 2015-06-20
- Project duration
- 30 months (the same as in the proposal)
- Project status
- Project settled
Information in the final report
Publication in academic press/journals (2)
-
Kinazy PIM jako cel terapeutyczny w nowotworach układów krwiotwórczego i chłonnego
- Authors:
- P. Juszczyński
- Academic press:
- Hematologia (year: 2014, volume: 5, pages: 305–316), Publisher: Via Medica
- Status:
- Published
-
Expression of PIM Kinases in Reed-Sternberg Cells Fosters Immune Privilege and Tumor Cell Survival in Classical Hodgkin Lymphoma
- Authors:
- Maciej Szydłowski, Monika Prochorec-Sobieszek, Anna Szumera-Ciećkiewicz, Grażyna Hoser, Ewa Jabłońska, Emilia Białopiotrowicz, Przemysław Kiliszek, Tomasz Sewastianik, Anna Polak, Wojciech Czardybon, Michał Gałęzowski, Renata Windak, Krzysztof Brzózka, Jan Maciej Zaucha, Krzysztof Warzocha, Przemysław Juszczyński
- Academic press:
- Blood (year: 2017, volume: n/a, pages: n/a), Publisher: American Society of Hematology
- Status:
- Published
- DOI:
- 10.1182/blood-2017-01-760702 – link to the publication